CMS, the best proxy to the Sarawak Corridor of Renewable Energy (SCORE), attracted keen institutional interest during our US non-deal roadshow (NDR). Investors see upside for its OMS associate and phosphate project under MPA given attractive power prices, while growth at its other units will be SCORE-driven. Reiterate BUY, with our SOP-based FV revised higher to MYR10.37 (from MYR9.22).
Revisiting Our SOP Valuation
Is there any more upside left? CMS’ share price has gained 191.2% barely one year since we initiated coverage, hitting a multiple-year high of MYR9.00 on 7 March 2014 as we ended our one-week NDR to the US. Although many investors we met during our roadshow raised concerns over its share price, which has tripled over the past year, most concurred that there is still upside given the group’s solid growth potential and valuation, which is still at a discount to its regional cement peers.
Should cement division trade on par with regional peers? After spending a year promoting the company, we believe that investors are beginning to understand how the group’s logistics edge allows it to maintain its tight grip on Sarawak’s cement market. We started coverage on CMS by valuing its cement division at half of its regional peers in terms of P/E ratio, but have since gradually cut this discount as investors’ knowledge on the unique cement market grew. In view of American investors’ understanding of CMS’ cement business, we think it is now time to remove our discount on this division. That said, we are valuing CMS’ cement division at 16.6x (vs 14.2x) FY14 earnings, which is on par with its South-East Asian peers, but still at a 20% discount to the valuation we accord to its West Malaysian peer, Lafarge (LMC MK, BUY, FV: MYR9.61), as the latter maintains a generous dividend payout of >90%.
RNAV for property division. In the past, we valued the group’s property division at a mere MYR270m, which implies only a 10x average PAT from 2014 to 2018. This is a far cry from the actual valuation on CMS’ landbank. Making a quick back-ofenvelope calculation to revalue its landbank in Kuching area, our computation shows that the remaining 3,700 acres in Bandar Baru Samariang alone could easily fetch MYR370m, or a net surplus after tax of some MYR267.8m, benchmarked against its last disposal to Sentoria (SNT MK, NR) in the same area. Based on the same calculation for its other land parcels to assess their net surpluses, we arrive at a total sum of MYR422.5m, ie after deducting the gains and applying a 25% corporate tax rate (see Figure 2).
SOP FV revised higher to MYR10.37. Aside from revising the value of its cement and property divisions, we also roll over our DCF valuation for CMS’ road maintenance and workers lodge divisions from FY13 to FY14, which results in marginal cuts in the value of both divisions. Apart from this, we also update the book value of associate, K&N Kenanga, with its latest FY13 numbers. From these changes, we derive a new FV of MYR10.37 (from MYR9.22), which we deem still far from the stock’s reasonable range. Stripping out the net cash from our valuation, our FV implies 1.6x P/BV and 14.2x FY14 EPS.
Key Assumptions
Financial Exhibits
SWOT Analysis
Company Profile
Cahya Mata Sarawak (CMS), a conglomerate with most of its operations based in Sarawak, has its main busines s in cement manufacturing. The group is also involved in building materials, construction, road maintenance and prope rty development.
Recommendation Chart
Source: RHB
Chart | Stock Name | Last | Change | Volume |
---|
Created by kiasutrader | Jun 14, 2016
Created by kiasutrader | May 05, 2016